Project Grant R42DE030040
- This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support a randomized clinical study led by Dr. Subramanian at Rutgers, The State University of New Jersey. The $168,228 award aims to evaluate the efficacy of a novel local anesthetic injection technique, the Temporo-Masseteric Nerve Block (TMNB), in reducing post-surgical pain and improving mouth opening for patients...
- Federal Project Grant Award Summary Periomics Care LLC received a $297,711 Phase I Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), awarded on August 6, 2025, with completion scheduled for July 31, 2027. The project focuses on developing and testing zinc tetraammine difluoride (ZAF), a novel nanocrystalline formulation designed to arrest dental caries and promote remineralization. This...
- This SBIR Phase I Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program provides $275,000 to T33 Dental, Inc. to validate a novel device and approach for enhancing the delivery of pharmaceuticals and cosmetics into whole human teeth. The project aims to develop a system to improve the permeability of drugs and cosmetic treatments for addressing tooth decay and enabling more effective dental procedures. Key focus areas...
- Federal Grant Award Summary Midwestern University received a $105,450 Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), effective July 1, 2025 through June 30, 2027. The award supports the development and feasibility testing of a Virtual Patient-Based Learning (VPBL) methodology for dental education in temporomandibular disorders (TMD). The project addresses critical gaps in TMD education...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research awarded a Project Grant of $239,405 to Massachusetts General Hospital (The General Hospital Corporation) for the period July 1, 2025 through June 30, 2027, under the Oral Diseases and Disorders Research program (CFDA 93.121). The research focuses on elucidating the neural circuit mechanisms underlying peripheral nerve stimulation (PNS) as a treatment for trigeminal neuropathic pain (TNP), a condition...
- Federal Project Grant Award Summary Oralmr LLC received a $341,970 Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), awarded September 4, 2025, with completion targeted for August 31, 2026. The grant supports the development and validation of a novel low-field magnetic resonance imaging (MRI) system designed specifically for dental applications. The project integrates an intraoral dental...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The University of Texas Health Science Center at San Antonio $449,861 under the Oral Diseases and Disorders Research program (CFDA 93.121) to conduct a 24-month clinical observational feasibility study examining dental practitioners' oral appliance therapy (OAT) titration methods for obstructive sleep apnea (OSA) and their associated patient outcomes. Initiated on June 17, 2025, the...
- The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $421,800 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to Midwestern University. The purpose of this 3-year grant, with a start date of September 7, 2023, is to develop hybrid hydrogel-based dental adhesives that are less vulnerable to hydrolytic degradation compared to current methacrylate-based alternatives. The goal is to create a truly biomimetic dental adhesive that can not only...
- This $349,996 federal Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program aims to develop a new dental technology to improve oral health through microbial transplantation. The project will test the use of beneficial oral microbes from healthy donor dental plaque to treat conditions like dental decay and gum disease in recipients. The effort will employ a 3D printed system to grow and propagate the transplanted microbes, with the...
- This Project Grant from the National Science Foundation's Engineering program (CFDA 47.041) provides $249,999 to The Trustees of the University of Pennsylvania for the development of a smart dental implant system. The award will support research and educational activities from September 2022 through August 2025. Specifically, the grantee will build a strategy to prevent peri-implant disease through enhancing soft tissue immunity near dental implants. They will develop an ambulatory care platform...
DISSEMINABLE EVIDENCE-BASED TREATMENT FOR THE DENTAL OFFICE: VIRTUAL EXPOSURE TOOLS FOR DENTAL FEAR - NEVR FEAR THE DENTIST - PROJECT SUMMARY/ABSTRACT EACH YEAR OVER 20 MILLION ADULTS WITH MODERATE FEAR AND OVER 14 MILLION ADULTS WITH SEVERE FEAR VISIT THE DENTIST. BECAUSE FEAR PORTENDS POOR FUTURE ORAL HEALTH, PATIENTS WITH DENTAL FEAR COME TO EXPERIENCE THEIR WORST FEARS: PAIN, SURGICAL PROCEDURES, AND THE NEED FOR MORE FREQUENT DENTAL VISITS. AVOIDANCE IS THE NATURAL AND REINFORCED RESPONSE, IRONICALLY GUARANTEEING A REPETITION OF THE FEARED EVENTS. BREAKING THIS CYCLE IS THE PRIMARY TARGET OF THIS PROPOSAL. STANDARD TREATMENT - COMPASSIONATE BUT ULTIMATELY COUNTERPRODUCTIVE - INCLUDES ANTI-ANXIETY MEDICATION OR MORE SUBSTANTIAL ANESTHESIA, WHICH (A) DOES NOTHING TO REDUCE SUBSEQUENT ANXIETY OR AVOIDANCE, (B) LEADS TO CONTINUED DENTAL PROBLEMS, AND (C) PERPETUATES THE CYCLE OF FEAR->AVOIDANCE->DENTAL PROBLEMS. ALTERNATIVELY, COGNITIVE-BEHAVIORAL TREATMENTS (CBT) FOR DENTAL FEAR HAVE BEEN DEVELOPED, SUBJECTED TO DOZENS OF HIGH-QUALITY TRIALS, AND FOUND TO BE EFFICACIOUS. HOWEVER, CBT HAS, ALMOST EXCLUSIVELY, BEEN OFFERED ONLY IN A FEW SPECIALTY CLINICS WORLDWIDE ASSOCIATED WITH UNIVERSITIES; THERE IS NO DISSEMINABLE MODEL FOR INTEGRATING CBT INTO THE WORKFLOW OF DENTAL PRACTICES. TO FILL THIS GAP, THIS FAST-TRACK STTR PROPOSAL DESCRIBES PLANS FOR DEVELOPMENT AND TESTING OF A MARKETABLE PRODUCT THAT CAN BRING EFFECTIVE DENTAL FEAR TREATMENT TO DENTAL OFFICES WITHIN THE CURRENTLY EXISTING U.S. PRACTICE ECOSYSTEM. NEVR FEAR THE DENTISTTM IS A COMMERCIALIZABLE SUITE OF SELF-ADMINISTERED EHEALTH TOOLS TO TREAT DENTAL FEAR THAT CAN BE IMPLEMENTED IN PRIVATE PRACTICE DENTAL OFFICES THROUGHOUT THE U.S. AND IS EMINENTLY SCALABLE. NEVR FEAR THE DENTISTTM COMPRISES THREE MAJOR EVIDENCE-BASED INTERVENTIONS. FIRST IS A SELF-ADMINISTERED EHEALTH APP FOR CBT/PSYCHOEDUCATION WITH EXPOSURE THERAPY - DELIVERED VIA A MOBILE TABLET - THAT CAN BE USED PRIVATELY IN WAITING ROOMS. SECOND IS A COMMUNICATION-ELICITING INTERVENTION, IN WHICH THE PATIENT RECORDS A "PRE-GAME PLAN" - TO BE REVIEWED WITH THE DENTAL STAFF BEFORE DENTAL SERVICES - COMPRISING (1) PRE-TREATMENT FEAR LEVELS, (2) THE FACTOR GENERATING THE MOST ANXIETY, (3) A STOP-SIGNAL THE PATIENT WILL USE TO ALERT DENTIST, (4) THINGS THE DENTAL TEAM CAN DO TO MAXIMIZE THIS PATIENT'S COMFORT, AND (5) A SELF-GENERATED ANXIETY MANAGEMENT PLAN. ALL PATIENTS IN THE TREATMENT GROUP WILL RECEIVE THE FIRST TWO EBIS AS A SINGLE INTERVENTION ON THE TABLET. THIRD (FOR PATIENTS WHO ARE IN THE SEVERE RANGE) IS A 1-HR VIRTUAL REALITY EXPOSURE TREATMENT (VRET). VRET WILL ALLOW US TO PROVIDE CBT THAT CAN BE SELF-ADMINISTERED WITHIN THE NORMAL OPERATIONS OF DENTISTRY AND WILL ALLOW EVERY DENTAL PRACTICE TO BE A DENTAL FEAR SPECIALTY CLINIC. SUCH AN APPROACH IS NECESSARY TO SHIFT CLINICAL PRACTICE, AS THE NEARLY 200,000 U.S. DENTISTS WILL ONLY ADOPT AN APPROACH DESIGNED, FROM THE BOTTOM UP, TO FIT BOTH THE BUSY-NESS AND BUSINESS OF 21ST-CENTURY DENTAL PRACTICES. THE RESEARCH COMPONENT WILL USE AN ADEQUATELY POWERED RCT TO TEST BOTH (A) THE EFFECTIVENESS OF NEVR FEAR THE DENTISTTM AND, USING THE NIH'S EXPERIMENTAL MEDICINE APPROACH TO BEHAVIORAL CHANGE MODEL, (B) WHETHER INHIBITORY LEARNING IS THE MECHANISM THROUGH WHICH IT AFFECTS CHANGE.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 8/13/25 | ||
| Not listed | $412.8k | 8/1/24 | ||
| Not listed | $0 | 7/25/24 | ||
| Not listed | $419.3k | 8/23/23 | ||
| Not listed | $419.3k | 8/23/23 |